Search research articles
Contact Us
Filters
Showing results (31-40 of 86) with videos related to
Page
of 9
Sort By:
Cell Death & Disease
|
October 5, 2013
EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells
K Rea, M Sensi, A Anichini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1997
TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients
C Maccalli, C Farina, M Sensi, et al.
Cancer Immunology, Immunotherapy : CII
|
May 11, 1999
High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition
P Pisarra, R Mortarini, S Salvi, et al.
Cancer Research
|
October 15, 1995
Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins
R Mortarini, A Gismondi, A Maggioni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 10, 1999
Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions
C Maccalli, P Pisarra, C Vegetti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 4, 1998
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination
M Sensi, C Farina, C Maccalli, et al.
International Journal of Cancer
|
May 29, 1996
Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis
C Cillo, M Cantile, R Mortarini, et al.
Tissue Antigens
|
July 24, 2002
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones
M Sensi, S Pellegatta, C Vegetti, et al.
Melanoma Research
|
February 1, 1994
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma
R Lupetti, M Sensi, R Mortarini, et al.
Journal of Immunogenetics
|
April 1, 1986
Phenotypic heterogeneity of HLA products on human melanoma cells
G Parmiani, D Taramelli, A Anichini, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 86) with videos related to
Sort By:
Page
of 9
Cell Death & Disease
|
October 5, 2013
EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells
K Rea, M Sensi, A Anichini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1997
TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients
C Maccalli, C Farina, M Sensi, et al.
Cancer Immunology, Immunotherapy : CII
|
May 11, 1999
High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition
P Pisarra, R Mortarini, S Salvi, et al.
Cancer Research
|
October 15, 1995
Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins
R Mortarini, A Gismondi, A Maggioni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 10, 1999
Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions
C Maccalli, P Pisarra, C Vegetti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 4, 1998
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination
M Sensi, C Farina, C Maccalli, et al.
International Journal of Cancer
|
May 29, 1996
Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis
C Cillo, M Cantile, R Mortarini, et al.
Tissue Antigens
|
July 24, 2002
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones
M Sensi, S Pellegatta, C Vegetti, et al.
Melanoma Research
|
February 1, 1994
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma
R Lupetti, M Sensi, R Mortarini, et al.
Journal of Immunogenetics
|
April 1, 1986
Phenotypic heterogeneity of HLA products on human melanoma cells
G Parmiani, D Taramelli, A Anichini, et al.
Page
of 9